drugset / Trial / NCT01690000

Treatment of Osteopenia With Melatonin

NCT01690000

Completed 81 enrolled University of Aarhus
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the study is to assess the effect of melatonin treatment in patients with osteopenia on BMD, muscle function, quality of life and calcium homeostasis.

Timeline

Start
2012-11
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Melatonin Small molecule 1 mg Oral
Comparator Melatonin Small molecule 3 mg Oral

Indications